• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

综述:动物辅助干预对注意力缺陷/多动障碍儿童的影响——一项系统综述和荟萃分析。

Review: Animal-assisted intervention for children with attention-deficit/hyperactivity disorder - a systematic review and meta-analysis.

作者信息

Yu Shuxin, Xue Hui, Xie Yuqing, Shao Guanyue, Hao Yihui, Fan Lijun, Du Wei

机构信息

School of Public Health, Southeast University, Nanjing, China.

Key Laboratory of Environmental Medicine Engineering, Ministry of Education, School of Public Health, Southeast University, Nanjing, Jiangsu, China.

出版信息

Child Adolesc Ment Health. 2025 Feb;30(1):34-52. doi: 10.1111/camh.12744. Epub 2025 Jan 10.

DOI:10.1111/camh.12744
PMID:39791320
Abstract

BACKGROUND

Animal-assisted interventions (AAIs) have emerged as a promising nonpharmacological intervention option for children diagnosed with attention-deficit/hyperactivity disorder (ADHD). However, recent systematic reviews have been primarily narrative. Additionally, the pooled effectiveness of AAIs was absent from these systematic reviews.

METHODS

We conducted a comprehensive systematic review and meta-analysis, searching multiple databases, including Web of Science, MEDLINE, CINAHL, Scopus, PsycINFO, EMBASE and Cochrane, from inception of the databases to March 2024. We retrieved 17 randomised controlled trials or quasi-experimental studies and used Review Manager 5.4.1 software to perform a meta-analysis of the effects of AAIs in treating children with ADHD. We conducted a set of random-effects meta-analyses to estimate standardised mean differences (SMD) with 95% confidence intervals (CI) using subgroup data by different outcome domains extracted from eight randomised controlled trials, in relation to changes in behavioural, mental and physical functioning in a total of 307 children with ADHD before and after the intervention.

RESULTS

In comparison with non-AAI groups, AAIs significantly improved attention problems in children with ADHD (SMD = -0.42, 95% CI = -0.71 to -0.13), self-esteem (0.46, 0.14 to 0.78), learning and cognition problems (-0.69, -0.98 to -0.39) and motor proficiency (0.77, 0.11 to 1.42). The pooled effect of AAIs on the severity of ADHD symptoms in the experimental group was not significantly different from the effect of conventional treatments in the control group (0.10, -0.31 to 0.52). Similarly, AAIs had no significant positive effects on social interaction (-0.22, -0.51 to 0.06), social skills (-0.32, -0.87 to 0.24), problematic behaviours (-0.10, -0.54 to 0.35) or emotional problems, including depression and anxiety (-0.13, -0.51 to 0.24).

CONCLUSIONS

As an ADHD management strategy complementary to gold-standard approaches, such as medication or multimodal interventions, AAIs did not appear to be more effective in improving the majority of core ADHD outcomes in children. Future studies should incorporate rigorous study designs with large sample sizes and a standard protocol to achieve more valid and reliable conclusion.

摘要

背景

动物辅助干预(AAIs)已成为一种有前景的非药物干预选择,用于治疗被诊断为注意力缺陷多动障碍(ADHD)的儿童。然而,最近的系统评价主要是叙述性的。此外,这些系统评价中缺乏AAIs的综合有效性。

方法

我们进行了一项全面的系统评价和荟萃分析,检索了多个数据库,包括Web of Science、MEDLINE、CINAHL、Scopus、PsycINFO、EMBASE和Cochrane,从数据库建立之初到2024年3月。我们检索到17项随机对照试验或准实验研究,并使用Review Manager 5.4.1软件对AAIs治疗ADHD儿童的效果进行荟萃分析。我们进行了一组随机效应荟萃分析,以估计标准化均数差(SMD)及其95%置信区间(CI),使用从8项随机对照试验中提取的不同结局领域的亚组数据,涉及307名ADHD儿童干预前后行为、心理和身体功能的变化。

结果

与非AAI组相比,AAIs显著改善了ADHD儿童的注意力问题(SMD = -0.42,95%CI = -0.71至-0.13)、自尊(0.46,0.14至0.78)、学习和认知问题(-0.69,-0.98至-0.39)以及运动能力(0.77,0.11至1.42)。AAIs对实验组ADHD症状严重程度的综合效应与对照组传统治疗的效应无显著差异(0.10,-0.31至0.52)。同样,AAIs对社交互动(-0.22,-0.51至0.06)、社交技能(-0.32,-0.87至0.24)、问题行为(-0.10,-0.54至0.35)或情绪问题(包括抑郁和焦虑)(-0.13,-0.51至0.24)没有显著的积极影响。

结论

作为一种与药物治疗或多模式干预等金标准方法互补的ADHD管理策略,AAIs在改善儿童大多数核心ADHD结局方面似乎并不更有效。未来的研究应采用严谨的研究设计和大样本量以及标准方案,以得出更有效和可靠的结论。

相似文献

1
Review: Animal-assisted intervention for children with attention-deficit/hyperactivity disorder - a systematic review and meta-analysis.综述:动物辅助干预对注意力缺陷/多动障碍儿童的影响——一项系统综述和荟萃分析。
Child Adolesc Ment Health. 2025 Feb;30(1):34-52. doi: 10.1111/camh.12744. Epub 2025 Jan 10.
2
Parent training interventions for Attention Deficit Hyperactivity Disorder (ADHD) in children aged 5 to 18 years.针对5至18岁儿童注意力缺陷多动障碍(ADHD)的家长培训干预措施。
Cochrane Database Syst Rev. 2011 Dec 7;2011(12):CD003018. doi: 10.1002/14651858.CD003018.pub3.
3
Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD).用于治疗儿童和青少年注意力缺陷多动障碍(ADHD)的哌甲酯。
Cochrane Database Syst Rev. 2015 Nov 25;2015(11):CD009885. doi: 10.1002/14651858.CD009885.pub2.
4
Methylphenidate for children and adolescents with autism spectrum disorder.用于治疗自闭症谱系障碍儿童和青少年的哌醋甲酯
Cochrane Database Syst Rev. 2017 Nov 21;11(11):CD011144. doi: 10.1002/14651858.CD011144.pub2.
5
Social skills training for Attention Deficit Hyperactivity Disorder (ADHD) in children aged 5 to 18 years.针对5至18岁儿童注意力缺陷多动障碍(ADHD)的社交技能训练。
Cochrane Database Syst Rev. 2011 Dec 7(12):CD008223. doi: 10.1002/14651858.CD008223.pub2.
6
Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD).哌醋甲酯治疗注意缺陷多动障碍(ADHD)儿童和青少年。
Cochrane Database Syst Rev. 2023 Mar 27;3(3):CD009885. doi: 10.1002/14651858.CD009885.pub3.
7
Polyunsaturated fatty acids (PUFA) for attention deficit hyperactivity disorder (ADHD) in children and adolescents.多不饱和脂肪酸(PUFA)治疗儿童和青少年注意缺陷多动障碍(ADHD)。
Cochrane Database Syst Rev. 2023 Apr 14;4(4):CD007986. doi: 10.1002/14651858.CD007986.pub3.
8
Immediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults.速释型哌甲酯用于治疗成人注意力缺陷多动障碍(ADHD)
Cochrane Database Syst Rev. 2014 Sep 18(9):CD005041. doi: 10.1002/14651858.CD005041.pub2.
9
Polyunsaturated fatty acids (PUFA) for attention deficit hyperactivity disorder (ADHD) in children and adolescents.用于治疗儿童和青少年注意力缺陷多动障碍(ADHD)的多不饱和脂肪酸(PUFA)
Cochrane Database Syst Rev. 2012 Jul 11;2012(7):CD007986. doi: 10.1002/14651858.CD007986.pub2.
10
Stimulant and non-stimulant drug therapy for people with attention deficit hyperactivity disorder and epilepsy.兴奋剂和非兴奋剂药物治疗注意缺陷多动障碍和癫痫患者。
Cochrane Database Syst Rev. 2022 Jul 13;7(7):CD013136. doi: 10.1002/14651858.CD013136.pub2.